Supportive mistletoe therapy in a patient with metastasised neuroblastoma

Kaestner, Jens; Schlodder, Dietrich; Preussler, Christfried; Gruhn, Bernd

doi:10.1136/bcr-2018-227652

Cited by 3 publications

(1 citation statement)

References 15 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Evaluated exceptions have shown that in particular, children may benefit from AST interventions [ 3 , 7 ]. The small body of research that does exist in pediatric oncology using AST has featured case studies highlighting safety [ 8 – 10 ] and quality of life for the young person [ 11 , 12 ] rather than results of planned clinical trials. Parents of children suffering from intensive chemotherapy view AST as a possible means of assisting their child through difficult circumstances, but at the same time, the potential side effects of AST necessitate better monitoring clinical trials [ 2 , 13 ].…”

Section: Introductionmentioning

confidence: 99%

Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background Integrative medicine is used frequently alongside chemotherapy treatment in pediatric oncology, but little is known about the influence on toxicity. This German, multi-center, open-label, randomized controlled trial assessed the effects of complementary treatments on toxicity related to intensive-phase chemotherapy treatment in children aged 1–18 with the primary outcome of the toxicity sum score. Secondary outcomes were chemotherapy-related toxicity, overall and event-free survival after 5 years in study patients. Methods Intervention and control were given standard chemotherapy according to malignancy & tumor type. The intervention arm was provided with anthroposophic supportive treatment (AST); given as anthroposophic base medication (AMP), as a base medication for all patients and additional on-demand treatment tailored to the intervention malignancy groups. The control was given no AMP. The toxicity sum score (TSS) was assessed using NCI-CTC scales. Results Data of 288 patients could be analyzed. Analysis did not reveal any statistically significant differences between the AST and the control group for the primary endpoint or the toxicity measures (secondary endpoints). Furthermore, groups did not differ significantly in the five-year overall and event-free survival follow up. Discussion In this trial findings showed that AST was able to be safely administered in a clinical setting, although no beneficial effects of AST between group toxicity scores, overall or event-free survival were shown.

show abstract

Section: Introductionmentioning

confidence: 99%

Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

Antineoplastics

2019

Reactions Weekly

View full text Add to dashboard Cite

Ultra-Diluted Viscum Album in the Treatment of Cutaneous Melanoma in a Dog (Canis Familiaris) - Case Report

Valle¹,

Carvalho²

2021

PIJR

View full text Add to dashboard Cite

Background: Cutaneous melanoma is one of the tumors with the highest incidence in middle-aged dogs. Effective systemic treatments for advanced malignant melanoma are lacking, and survival is about 1 to 3 months. Viscum album therapy is among the complementary therapies against cancer. A 7-year-old Dogue de Bordeaux female d Methods: og. The main complaint was an ulcerated lesion in the right anterior leg. The animal had already been diagnosed with malignant cutaneous melanoma 11 months before. Extensive ulcerated lesions in the fourth digit of the right anterior leg, mandibular region, and labial commissures were observed for more than nine months, with no resolution of the initial condition. Pulmonary metastasis in the left caudal lobe, two evolving breast tumors, and several blackish nodular lesions spread through the abdomen, lower eyelids, and auricular pavilions were already diagnosed. An injectable, -3 homeopathic treatment was prescribed and consisted of an intravenous application of Viscum album D3 (1x10 ) and -3 -6 auto-hemotherapy, once a week. At home, the tutor performed applications of Viscum album D3 (1x10 ), D6 (1x10 ), D12 -12 -30 (1x10 ), D30 (1x10 ), in combinations, SID, subcutaneously, three times a week. The protocol administ Conclusion: ered to the patient in this study was successful in its purpose. It healed the wounds and improved the patient's quality of life. Other studies must be conducted, under the same conditions, to better elucidate the results obtained in the present study.

show abstract

Supportive mistletoe therapy in a patient with metastasised neuroblastoma

Cited by 3 publications

References 15 publications

Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up

Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up

Antineoplastics

Ultra-Diluted Viscum Album in the Treatment of Cutaneous Melanoma in a Dog (Canis Familiaris) - Case Report

Contact Info

Product

Resources

About